Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

INTRODUCTION: Interleukin-6 (IL-6) is an important growth factor for estrogen receptor-α (ERα)-positive breast cancer, and elevated serum IL-6 is associated with poor prognosis. METHODS: The role of the phosphorylated signal transducer and activator of transcription 3 pathway was investigated in ERα...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer (Dove Med Press)
Main Authors: Casneuf, Tineke, Axel, Amy E, King, Peter, Alvarez, John D, Werbeck, Jillian L, Verhulst, Tinne, Verstraeten, Karin, Hall, Brett M, Sasser, A Kate
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745841/
https://ncbi.nlm.nih.gov/pubmed/26893580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S92414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados